The country and blues singer has been openly battling a rare cancer, and he recently revealed that the disease has grown in ...
A new pancreatic cancer treatment targeting the KRAS gene mutation represents a major breakthrough, offering the first ...
Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...
South Korean researchers have developed a new antibody capable of precisely targeting mutations in hard-to-treat cancers — ...
The tumour microenvironment also makes pancreatic cancer highly resistant to treatment. The tumour is surrounded by dense ...
2don MSNOpinion
Big pharma’s patent cliff meets a new biotech Cold War: We need to outrun China, not outlaw it
If we slash federal research budgets, we risk hamstringing our scientists and losing an otherwise winnable race.
Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have ...
New KRAS-targeting drug for metastatic pancreatic cancer nearly doubles second-line survival; expert explains impact, side effects, next trials.
Background New-onset diabetes (NOD) increases the risk of pancreatic cancer. Previous studies have mainly focused on the ...
Sita Kugel, PhD, is the inaugural recipient of the Leung Roy Family Endowed Chair. She investigates the molecular drivers of cancer and looks for ways to target them with small molecules and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results